Have you stopped receiving our weekly e-newsletter?

Europe

Author: Joe McAweaneyPublished: 12 July 2018

Prep: Cook: Serves:

Due to recent changes in EU law, you must ‘opt-in’ to continue to receive our e-newsletter

On 25 May 2018 General Data Protection Regulation (GDPR) laws were passed by the European Union, significantly changing the ways in which businesses and public sector organisations must handle data.

The new laws mean that all consumer information held before this date must be deleted, meaning that people must ‘opt-in’ to keep receiving communications from organisations. For Parkinson’s Life, this means that if you want to keep receiving our weekly e-mail newsletter you must let us know – regardless of whether you have signed up in the past or not. Legally, we must delete your data and cannot communicate with you if you have not signed up.

To sign up, please click ‘subscribe’ in the top right hand corner of our website and fill out the form.

We are very proud of the work we do here at Parkinson’s Life, and are looking forward to communicating with as many of you as possible in the future.

Last Month

Next Month

Go Back

Share this story

Comments

Perspectives

Who said what: QoTW 28.05.15

Our favourite quotes of the week from around the web

Cambridge University gets go-ahead for new £22m Parkinson’s research centre

Cambridge Uni to build ‘state-of-the-art’ Parkinson's research facility

“Life can still be fun if you have Parkinson’s”

The latest in our monthly series profiling WPC2019 bloggers

Could a transplant lower the risk of Parkinson’s?

Researchers at Washington University School of Medicine, US, have found that having a heart, kidney, lung or bone marrow transplant could reduce the risk of developing Parkinson’s. As part of the study, published in medical journal ‘Parkinsonism & Related Disorders’, the team assessed data of just under 200,000 patients – 89,790 of whom had Parkinson’s. The results revealed that individuals who had a transplant were 37% less likely to develop Parkinson’s. This could be due to the immunosuppressant medication patients receive before undergoing a transplant, which researchers believe may help slow neurodegeneration as it reduces inflammation in the brain. The study said: “This study provides evidence that tissue transplant may be associated with a lower PD [Parkinson’s disease] risk, warranting further investigation to identify factors that mediate this relationship.”

Groundbreaking Parkinson’s trial publishes results

A breakthrough Parkinson’s trial that featured in a two-part documentary on UK television channel BBC Two has published its results. The study, which featured in the documentary ‘The Parkinson’s Drug Trial: A miracle cure?’, aimed to investigate whether it was possible to restore damaged neurons by administering protein Glial Cell Line Derived Neurotrophic Factor (GDNF). As part of the trial, scientists initially infused GDNF into the brains of six participants living with the condition. Researchers then invited a further 35 individuals with Parkinson’s to take part, with approximately half being administered with a placebo infusion. Although not conclusive, the results suggest that GDNF had an impact on the brain and researchers believe the topic is worthy of further study. Dr Alan Whone, principal investigator on the trial, said: “This represents some of the most compelling evidence yet that we may have a means to possibly reawaken and restore the dopamine brain cells…

Course for Parkinson’s nurses launches in Slovenia

The International Parkinson and Movement Disorder Society is hosting its third summer school for nurses specialising in Parkinson’s. The course – which will be held from 10-12 May in Ljubljana, Slovenia – will focus on the management of the motor and non-motor symptoms of the condition. Students will also attend lectures, examine Parkinson’s patients and discuss treatment plans with experts. All lectures will be presented in English. Heather Vitale, senior programme manager at the International Parkinson and Movement Disorder Society, said: “This course offers a unique opportunity for nurses to enhance their knowledge in Parkinson’s disease, while also learning and networking with their peers through case study presentations and small group discussions.” Registration closes 26 April 2019 and costs USD $350.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Phone
This field is for validation purposes and should be left unchanged.

Have you stopped receiving our weekly e-newsletter?

Europe

Author: Joe McAweaneyPublished: 12 July 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Perspectives

Who said what: QoTW 28.05.15

Advances

Cambridge University gets go-ahead for new £22m Parkinson’s research centre

Interviews

“Life can still be fun if you have Parkinson’s”

Could a transplant lower the risk of Parkinson’s?

Groundbreaking Parkinson’s trial publishes results

Course for Parkinson’s nurses launches in Slovenia

{title}

Subscribe

Have you stopped receiving our weekly e-newsletter?

Europe

Author: Joe McAweaneyPublished: 12 July 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Perspectives

Who said what: QoTW 28.05.15

Advances

Cambridge University gets go-ahead for new £22m Parkinson’s research centre

Interviews

“Life can still be fun if you have Parkinson’s”

Could a transplant lower the risk of Parkinson’s?

Groundbreaking Parkinson’s trial publishes results

Course for Parkinson’s nurses launches in Slovenia

{title}

Subscribe

Sign in